Inventor · disambiguated record
Alfredo Nicosia
Also filed as: NICOSIA ALFREDO
30 granted patents·19 pending applications·200 citations·filing 1990–2024
96Inventor score
Files withGLAXOSMITHKLINE BIOLOGICALS SA15NOUSCOM AG7COLLOCA STEFANO4ANGELETTI P IST RICHERCHE BIO2CHIRON SPA2
Top patents by PatentIndex Score
49 records- 0190US9718863B2Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereofCOLLOCA STEFANO·Filed 2010·Granted Aug 1, 2017·19 cites·14 claims
- 0290US9056090B2Hepatitis C virus nucleic acid vaccineCOLLOCA STEFANO·Filed 2006·Granted Jun 16, 2015·19 cites·18 claims
- 0389US10544192B2Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Jan 28, 2020·8 cites·3 claims
- 0488US9526777B2Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoproteinSULLIVAN NANCY J·Filed 2011·Granted Dec 27, 2016·7 cites·5 claims
- 0587US8216834B2Chimpanzee adenovirus vaccine carriersCOLLOCA STEFANO·Filed 2005·Granted Jul 10, 2012·29 cites·11 claims
- 0686US7598362B2Hepatitis C virus vaccineMERCK & CO INC·Filed 2002·Granted Oct 6, 2009·12 cites·50 claims
- 0784US11912743B2Compositition and uses of teleost invariant chain to enhance T cell response to a vaccineNOUSCOM AG·Filed 2018·Granted Feb 27, 2024·3 cites·9 claims
- 0884US8673319B2Chimpanzee adenovirus vaccine carriersCOLLOCA STEFANO·Filed 2012·Granted Mar 18, 2014·13 cites·27 claims
- 0983US11254710B2Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Feb 22, 2022·2 cites·12 claims
- 1080US2024075125A1Expression systemsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2023·Application pending·0 cites
- 1178US11643666B2Eukaryotic cell lineNOUSCOM AG·Filed 2018·Granted May 9, 2023·1 cites·13 claims
- 1278US10576143B2Poxviral vaccinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Mar 3, 2020·1 cites·12 claims
- 1376US11913013B2Chimpanzee adenoviral vector-based filovirus vaccinesUS GOV HEALTH & HUMAN SERVICES·Filed 2021·Granted Feb 27, 2024·0 cites·5 claims
- 1474US11214599B2Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Granted Jan 4, 2022·0 cites·17 claims
- 1574US2022220157A1Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 1674US2024091338A1Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2023·Application pending·0 cites
- 1773US5994083AProcess for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainableISTITUTO DI RECERCHE DI BIOLOG·Filed 1994·Granted Nov 30, 1999·45 cites·8 claims
- 1873US2022204566A1Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 1970US8142794B2Hepatitis C virus vaccineEMINI EMILIO A·Filed 2009·Granted Mar 27, 2012·1 cites·27 claims
- 2069US11701422B2Expression systemsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Jul 18, 2023·0 cites·16 claims
- 2169US11278614B2Poxviral vaccinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Mar 22, 2022·0 cites·7 claims
- 2267US2020149069A1Chimpanzee adenoviral vector-based filovirus vaccinesTHE GOVERNMENT OF THE US SECRETARY OF THE DEPARTMENT OF·Filed 2020·Application pending·0 cites
- 2365US2021060150A1Novel adenovirusGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Application pending·0 cites
- 2464US10584355B2Chimpanzee adenoviral vector-based filovirus vaccinesUS GOV HEALTH & HUMAN SERVICES·Filed 2016·Granted Mar 10, 2020·0 cites·16 claims
- 2562US2025109205A1Antagonistic pd-1, pd-l1 and lag-3 binding proteinsCEINGE BIOTECNOLOGIE AVANZATE FRANCO SALVATORE SCARL·Filed 2024·Application pending·0 cites
- 2661US11254711B2Adenovirus polynucleotides and polypeptidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Feb 22, 2022·0 cites·16 claims
- 2761US5427788APertussis toxin and use in vaccinesSCLAVO SPA·Filed 1994·Granted Jun 27, 1995·22 cites·6 claims
- 2857US2016000904A1Improved poxviral vaccinesGLAXOSMITHKLINE BIOLOG SA·Filed 2014·Application pending·0 cites
- 2955US5785971APertussis toxin and use in vaccinesCHIRON SPA·Filed 1995·Granted Jul 28, 1998·12 cites·2 claims
- 3054US2007259959A1Ppar Agonists for the Treatment of Hcv InfectionCORTESE RICCARDO·Filed 2004·Application pending·0 cites
- 3153US2014141042A1Expression SystemsVITELLI ALESSANDRA·Filed 2011·Application pending·0 cites
- 3252US11578109B2Universal vaccine based on shared tumor neoantigens for prevention and treatment of micro satellite instable (MSI) cancersNOUSCOM AG·Filed 2018·Granted Feb 14, 2023·0 cites·8 claims
- 3352US10588961B2Poxviral vaccinesGLAXOSMITHLKINE BIOLOGICALS SA·Filed 2017·Granted Mar 17, 2020·0 cites·12 claims
- 3452US2011129498A1Vaccine for the prevention and therapy of hcv infectionsOKAIROS AG·Filed 2009·Application pending·0 cites
- 3552US2018256704A1Novel Prime-Boosting Regimens Involving Immunogenic Polypeptides Encoded by PolynucleotidesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Application pending·0 cites
- 3652US2015209420A1Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotidesOKAIROS SA·Filed 2013·Application pending·0 cites
- 3751US2017049879A1Expression systemsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Application pending·0 cites
- 3850US2024269272A1Vaccine composition comprising encoded adjuvantNOUSCOM AG·Filed 2022·Application pending·0 cites
- 3947US2021379170A1Selection of cancer mutations for generation of a personalized cancer vaccineNOUSCOM AG·Filed 2019·Application pending·0 cites
- 4045US11098324B2Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereofNOUSCOM AG·Filed 2018·Granted Aug 24, 2021·0 cites·15 claims
- 4143US2021154277A1Immunotherapeutic combination for treating cancerNEKTAR THERAPEUTICS·Filed 2018·Application pending·0 cites
- 4242US12152074B2Antagonistic PD-1, PD-L1 and LAG-3 binding proteinsKEIRES AG·Filed 2019·Granted Nov 26, 2024·0 cites·14 claims
- 4342US6350612B1Isolation and expression of DNA sequence encoding the five subunits of Bordetella pertussis toxinCHIRON SPA·Filed 1990·Granted Feb 26, 2002·6 cites·17 claims
- 4441US7928193B2Antigen binding proteins directed against scavenger receptor B1 that inhibit HCV replicationANGELETTI P IST RICHERCHE BIO·Filed 2005·Granted Apr 19, 2011·0 cites·6 claims
- 4536US2020230220A1Neoantigen vaccine composition for treatment of cancerNOUSCOM AG·Filed 2018·Application pending·0 cites
- 4635US11498956B2Fusion peptides with antigens linked to short fragments of invariant chain(CD74)GLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Nov 15, 2022·0 cites·19 claims
- 4733US2013150563A1Lipid-conjugated antibodiesPESSI ANTONELLO·Filed 2011·Application pending·0 cites
- 4827US7034108B1Mimotopes of hypervariable region 1 of the E2 glycoprotein of HCV and uses thereofANGELETTI P IST RICHERCHE BIO·Filed 1999·Granted Apr 25, 2006·0 cites·6 claims
- 4927US6541210B1Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainableISTITUTO DI RECERCHE DI BIOLOG·Filed 1999·Granted Apr 1, 2003·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Alfredo Nicosia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →